I read with interest the editorial 'Can I read with interest the editorial 'Can psychedelics have a role in psychiatry once psychedelics have a role in psychiatry once again? ' (Sessa, 2005) . Aside from overagain? ' (Sessa, 2005) . Aside from overcoming current legislative barriers, attencoming current legislative barriers, attention needs to be given to education about tion needs to be given to education about known research into this field, a function known research into this field, a function which this editorial usefully starts to fulfil. which this editorial usefully starts to fulfil.
The concern remains that the image of The concern remains that the image of psychedelics was not shaped by the already psychedelics was not shaped by the already existing extensive professional literature, existing extensive professional literature, but by the mass media sensationalising but by the mass media sensationalising the accidents of unsupervised selfthe accidents of unsupervised selfexperimentation (Grof, 2001) . It could experimentation (Grof, 2001) . It could therefore be surmised that decisive therefore be surmised that decisive influences will be a variety of political, influences will be a variety of political, legal, economic and mass-psychological legal, economic and mass-psychological factors, rather than the results of current factors, rather than the results of current and ongoing scientific research. Interest and ongoing scientific research. Interest from the psychiatric community will be from the psychiatric community will be paramount if this research information is paramount if this research information is to be critically reviewed with a view to clinto be critically reviewed with a view to clinical application. ical application.
The difference between psychedelics The difference between psychedelics (entheogens) and other psychotropic drugs (entheogens) and other psychotropic drugs is that entheogens work as 'non-specific is that entheogens work as 'non-specific amplifiers of the psyche', inducing an amplifiers of the psyche', inducing an altered or non-ordinary state of consciousaltered or non-ordinary state of consciousness (Grof, 2000) . The content and nature ness (Grof, 2000) . The content and nature of the experiences are not thought to be of the experiences are not thought to be artificial products of their pharmacological artificial products of their pharmacological interaction with the brain ('toxic psyinteraction with the brain ('toxic psychoses') but authentic expressions of the choses') but authentic expressions of the psyche revealing its functioning on levels psyche revealing its functioning on levels not ordinarily available for observation not ordinarily available for observation and study. In order to conceptualise this, and study. In order to conceptualise this, a vastly extended cartography of the psyche a vastly extended cartography of the psyche (Grof, 2000) , one which challenges our (Grof, 2000) , one which challenges our biomedical psychiatric model, is required. biomedical psychiatric model, is required.
Within psychiatry, entheogenic subWithin psychiatry, entheogenic substances (one of several methods of inducing stances (one of several methods of inducing a non-ordinary state of consciousness) a non-ordinary state of consciousness) could contribute to a powerful form of excould contribute to a powerful form of experiential psychotherapy; an important periential psychotherapy; an important addition to a psychiatric armamentarium, addition to a psychiatric armamentarium, working with domains of the psyche working with domains of the psyche traditionally ignored in our ethnocentric traditionally ignored in our ethnocentric Western model (Schlitz Western model (Schlitz et al et al, 2005) . , 2005). Potential credence for this field depends Potential credence for this field depends upon whether we view all non-ordinary upon whether we view all non-ordinary states of consciousness as pathological or states of consciousness as pathological or whether in some cases, some 'psychotic' whether in some cases, some 'psychotic' experiences can be seen to have potential experiences can be seen to have potential value as well as being potentially damaging. value as well as being potentially damaging. There is ongoing interest among mental There is ongoing interest among mental health professionals in the concept of health professionals in the concept of spiritual emergence as well as the theraspiritual emergence as well as the therapeutic power of altered states of conpeutic power of altered states of consciousness, the subject of a recent 1 day sciousness, the subject of a recent 1 day meeting held jointly with the Royal meeting held jointly with the Royal College of Psychiatrists and the Royal College of Psychiatrists and the Royal Society of Medicine (http://www.rcpsych. Society of Medicine (http://www.rcpsych. ac.uk/college/sig/spirit/index.asp). I would ac.uk/college/sig/spirit/index.asp). I would certainly value a continuing debate certainly value a continuing debate exploring this area. exploring this area.
The editorial by Dr Sessa is both timely and The editorial by Dr Sessa is both timely and encouraging. The almost complete denial, encouraging. The almost complete denial, not only by the media but also by the not only by the media but also by the psychiatric establishment, that lysergic psychiatric establishment, that lysergic acid diethylamide (LSD) and related acid diethylamide (LSD) and related psychedelics had an important place in the psychedelics had an important place in the therapy of a wide range of psychoneurotic therapy of a wide range of psychoneurotic disorders is astonishing. This clearly has a disorders is astonishing. This clearly has a psychodynamic explanation. psychodynamic explanation.
The interest shown during the 1950s The interest shown during the 1950s and 1960s by the psychiatric establishment and 1960s by the psychiatric establishment in the use of the psycholytic agents is even in the use of the psycholytic agents is even greater than Dr Sessa indicates. The greater than Dr Sessa indicates. The meeting of the 'American Psychological meeting of the 'American Psychological Association' at which the therapeutic use Association' at which the therapeutic use of LSD was discussed was actually held at of LSD was discussed was actually held at the Annual Meeting of the prestigious the Annual Meeting of the prestigious American Psychiatric Association, in American Psychiatric Association, in 1955 , rather than 1951 (Cholden, 1956 ). 1955 , rather than 1951 (Cholden, 1956 ). Subsequently, the role of psychedelics in Subsequently, the role of psychedelics in therapy was the subject of a number of therapy was the subject of a number of national and international conferences. national and international conferences. Perhaps the most significant of these was Perhaps the most significant of these was held in London in February 1961, when held in London in February 1961, when the Royal Medico-Psychological Associathe Royal Medico-Psychological Association, the forerunner of the Royal College tion, the forerunner of the Royal College of Psychiatrists, devoted the whole of its 3 of Psychiatrists, devoted the whole of its 3 day quarterly meeting to the subject day quarterly meeting to the subject (Crocket (Crocket et al et al, 1963) . , 1963). Dr Sessa touches briefly on the question Dr Sessa touches briefly on the question of the possible resumption of psycholytic of the possible resumption of psycholytic therapy. There have been a number of therapy. There have been a number of recent suggestions that this could once recent suggestions that this could once more become a possibility. Psychiatrists more become a possibility. Psychiatrists tempted to enter this field (assuming that tempted to enter this field (assuming that the appropriate drugs -LSD, 3,4-methylthe appropriate drugs -LSD, 3,4-methylenedioxymethamphetamine (MDMA), enedioxymethamphetamine (MDMA), psilocybin -are made legally available to psilocybin -are made legally available to doctors) should bear in mind that the doctors) should bear in mind that the success of psycholytic therapy depended success of psycholytic therapy depended on careful training, not only of the theraon careful training, not only of the therapist, but also of the nurses and others pist, but also of the nurses and others who formed the therapeutic team. That who formed the therapeutic team. That expertise at one time reached a high level, expertise at one time reached a high level, and all that has been lost. My hope is that and all that has been lost. My hope is that research and practice will continue, and research and practice will continue, and that it will be supported by the College. that it will be supported by the College. Dr Sessa is to be congratulated on his Dr Sessa is to be congratulated on his welcome review of research into psychewelcome review of research into psychedelic drugs. We are reminded of the hope delic drugs. We are reminded of the hope that these drugs 'could be for psychiatry that these drugs 'could be for psychiatry what the microscope is for biology or the what the microscope is for biology or the telescope is to astronomy: an essential tool telescope is to astronomy: an essential tool to explore the parts of the internal world to explore the parts of the internal world that are usually inaccessible'. that are usually inaccessible '. Grof (1975 '. Grof ( , 1990 has been the most Grof (1975 Grof ( , 1990 has been the most prominent explorer of these inaccessible prominent explorer of these inaccessible regions for over 40 years and once research regions for over 40 years and once research into lysergic acid diethylamide (LSD) into lysergic acid diethylamide (LSD) became impossible, developed a technique became impossible, developed a technique for inducing non-ordinary states of confor inducing non-ordinary states of consciousness called 'holotropic breathwork'. sciousness called 'holotropic breathwork'. This offers many of the features of the This offers many of the features of the psychedelic state without the need to take psychedelic state without the need to take a drug. Using insights from the use of a drug. Using insights from the use of LSD and holotropic breathwork in thou-LSD and holotropic breathwork in thousands of people, Grof (1975) proposed an sands of people, Grof (1975) proposed an extended model of the psyche with extended model of the psyche with psychodynamic, perinatal and transpsychodynamic, perinatal and transpersonal layers. These are provocative personal layers. These are provocative models of mind which challenge existing models of mind which challenge existing Western paradigms of consciousness and Western paradigms of consciousness and which probably reinforce mainstream which probably reinforce mainstream suspicion of any insights purporting to arise suspicion of any insights purporting to arise from the psychedelic experience. However, from the psychedelic experience. However, they do represent a serious attempt to they do represent a serious attempt to explore, describe and understand the explore, describe and understand the complex features of the non-ordinary state complex features of the non-ordinary state of consciousness and its theoretical of consciousness and its theoretical implications. implications.
Holotropic breathwork is marketed Holotropic breathwork is marketed more as a means of personal exploration more as a means of personal exploration than psychotherapy, but careful preparathan psychotherapy, but careful preparation, the context, a highly supportive tion, the context, a highly supportive setting and integration after the nonsetting and integration after the nonordinary state of consciousness are deemed ordinary state of consciousness are deemed crucial if the experience is to have value crucial if the experience is to have value (Grof, 1990 ). This approach is in contrast (Grof, 1990 ). This approach is in contrast to the views of Strassman (http://www. to the views of Strassman (http://www. tripzine.com/interviews.asp?id tripzine.com/interviews.asp?id¼strassman) strassman) who researched the use of N,N-dimethylwho researched the use of N,N-dimethyltryptamine (DMT) in 65 volunteers betryptamine (DMT) in 65 volunteers between 1990 and 1995 in a hospital tween 1990 and 1995 in a hospital setting with little attention to the setting with little attention to the surroundings. Strassman (2000) concluded surroundings. Strassman (2000) concluded that DMT probably did not have a that DMT probably did not have a beneficial effect in itself, that its use was beneficial effect in itself, that its use was high risk and that psychiatrists generally high risk and that psychiatrists generally did not have the experience, sensitivity or did not have the experience, sensitivity or training to support, contain, direct or training to support, contain, direct or interpret the more unusual experiences interpret the more unusual experiences that arise. Thus, although the drug is easily that arise. Thus, although the drug is easily taken, the context and setting is a little taken, the context and setting is a little more complicated and is at least as more complicated and is at least as important. important.
My point is that psychedelic drugs are My point is that psychedelic drugs are just one of a number of methods for the just one of a number of methods for the induction of a non-ordinary state of coninduction of a non-ordinary state of consciousness. Non-drug methods for the sciousness. Non-drug methods for the induction, exploration of and therapeutic induction, exploration of and therapeutic uses for non-ordinary states of conscioususes for non-ordinary states of consciousness may prove to be more productive for ness may prove to be more productive for psychiatrists interested in this area, given psychiatrists interested in this area, given the controversy that the use of psychedelic the controversy that the use of psychedelic drugs will always arouse. drugs will always arouse. Within the historical frame one could Within the historical frame one could argue that the proper subject for the case argue that the proper subject for the case study is the conduct and attitude of the prostudy is the conduct and attitude of the professionals who were the enthusiasts of that fessionals who were the enthusiasts of that time. The tone of the contemporary publitime. The tone of the contemporary publications was in general remarkable for a cations was in general remarkable for a willingness to get ahead of the research willingness to get ahead of the research evidence, and rush to positive and at times evidence, and rush to positive and at times even messianic conclusions. Here are some even messianic conclusions. Here are some examples of writings within that genre: examples of writings within that genre: 'These agents have a part to play in our 'These agents have a part to play in our survival as a species . . . ' (Osmond, 1957) ; survival as a species . . . ' (Osmond, 1957) ; 'The wonder of LSD is that it can bring 'The wonder of LSD is that it can bring within the capabilities of ordinary people within the capabilities of ordinary people the experience of universal love' (Davidson, the experience of universal love ' (Davidson, 1961) ; 'I feel that those on the moving edge 1961); 'I feel that those on the moving edge of new culture will eventually use these of new culture will eventually use these tools in a way that will utterly transform tools in a way that will utterly transform the nature of human consciousness' the nature of human consciousness' (Einhorn, 1971) . (Einhorn, 1971) .
What one sees in those kinds of stateWhat one sees in those kinds of statements is the dubious ambition of therapists ments is the dubious ambition of therapists to gain possession of chemical magic and to gain possession of chemical magic and exert power over their drugged patientsexert power over their drugged patientsthe therapist as shaman rather than as the therapist as shaman rather than as evidence-based practitioner. But that I'm evidence-based practitioner. But that I'm sure is not Dr Sessa's intention. sure is not Dr Sessa's intention. Grof (1990) , the breathwork developed by Grof (1990) , humankind has historically used meditahumankind has historically used meditation, exercise, fasting, chanting, dancing tion, exercise, fasting, chanting, dancing and even sex to induce transforming and even sex to induce transforming internal changes. What all these states internal changes. What all these states have in common is the final goal of have in common is the final goal of increased awareness and a loosening of increased awareness and a loosening of the ego -facilitating personal exploration the ego -facilitating personal exploration and being useful therapeutically to aid and being useful therapeutically to aid psychotherapy. As well as non-drugpsychotherapy. As well as non-drugi induced non-ordinary states of consciousnduced non-ordinary states of consciousness, psychedelics may have an important ness, psychedelics may have an important role to play -both in psychotherapy and role to play -both in psychotherapy and in the scientific study of consciousness. in the scientific study of consciousness.
I agree with Dr Edward's comments I agree with Dr Edward's comments about statements made by some overenthuabout statements made by some overenthusiastic individuals of the psychedelic movesiastic individuals of the psychedelic movement. Many clinicians of the 1960s (not to ment. Many clinicians of the 1960s (not to mention writers, artists and pop stars) saw mention writers, artists and pop stars) saw LSD as a magic wand, a common panacea LSD as a magic wand, a common panacea to assure 'better living through chemistry'. to assure 'better living through chemistry'. It was this attitude that killed genuine It was this attitude that killed genuine scientific study and kept the therapeutic scientific study and kept the therapeutic potential of psychedelics shelved for so potential of psychedelics shelved for so long. long.
Psychedelics cannot save the world, but Psychedelics cannot save the world, but they may have a role to play as adjuncts they may have a role to play as adjuncts to the psychotherapeutic treatment of to the psychotherapeutic treatment of neuroses. We must at least study and neuroses. We must at least study and research their potential with modern ranresearch their potential with modern randomised controlled trials. For the hundreds domised controlled trials. For the hundreds of clinicians and thousands of patients of of clinicians and thousands of patients of the 1950s and 1960s that witnessed the safe the 1950s and 1960s that witnessed the safe and effective usage of psychedelics, these and effective usage of psychedelics, these substances did appear to be useful (Masters substances did appear to be useful (Masters & Houston, 1973) . But as a profession we & Houston, 1973). But as a profession we need to distance ourselves from the need to distance ourselves from the Timothy Leary-esque, messianic approach Timothy Leary-esque, messianic approach to psychedelics, if we are to allow a disto psychedelics, if we are to allow a dispassionate and scientific study of their passionate and scientific study of their potential. potential.
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I was pleased to read Dr Crowley's I was pleased to read Dr Crowley's in-depth understanding of the complexity in-depth understanding of the complexity and value of the altered state of and value of the altered state of consciousness. Thankfully, there are cliniconsciousness. Thankfully, there are clinicians such as Dr Crowley with the concians such as Dr Crowley with the confidence not to dismiss the non-ordinary fidence not to dismiss the non-ordinary state of consciousness as mere 'acute confustate of consciousness as mere 'acute confusion', but to believe that psychedelics, and sion', but to believe that psychedelics, and non-drug non-ordinary states of consciousnon-drug non-ordinary states of consciousness, can inform and enlighten us with new ness, can inform and enlighten us with new approaches to understanding the mechanapproaches to understanding the mechanisms (and associated pathologies) of the isms (and associated pathologies) of the brain. Since the earliest human societies brain. Since the earliest human societies we have sought knowledge and healing we have sought knowledge and healing from these states -perhaps now this techfrom these states -perhaps now this technique can be utilised in a scientific and nique can be utilised in a scientific and evidence-based approach to relieve the burevidence-based approach to relieve the burden of anxiety disorders for today's patients. den of anxiety disorders for today's patients.
I am most grateful to Dr Sandison for I am most grateful to Dr Sandison for his kind and supportive words -and thank his kind and supportive words -and thank him for the correction regarding the date of him for the correction regarding the date of the American Psychiatric Association conthe American Psychiatric Association conference in 1955. I share his astonishment ference in 1955. I share his astonishment at the medical profession's inability or at the medical profession's inability or unwillingness to embrace the therapeutic unwillingness to embrace the therapeutic potential of psychedelic substances. This potential of psychedelic substances. This shortcoming is augmented by the fact that shortcoming is augmented by the fact that the hiatus in research over the past 40 years the hiatus in research over the past 40 years appears to have been for socio-political appears to have been for socio-political rather than scientific reasons -and it is rather than scientific reasons -and it is those pioneering psychiatrists like Dr those pioneering psychiatrists like Dr Sandison who are right to feel disheartened. Sandison who are right to feel disheartened.
I am enthusiastic, however, at the I am enthusiastic, however, at the current re-emergence of interest in this current re-emergence of interest in this field. There are increasing numbers of field. There are increasing numbers of randomised controlled trials of psychedelics randomised controlled trials of psychedelics (largely from the USA) and these may yield (largely from the USA) and these may yield results that guide future therapeutic results that guide future therapeutic applications (http://www.maps.org; http:// applications (http://www.maps.org; http:// www.heffter.org). There is also increasing www.heffter.org). There is also increasing interest in using psychedelics in consciousinterest in using psychedelics in consciousness research in the UK (http://www. ness research in the UK (http://www. beckleyfoundation.org). beckleyfoundation.org).
I do hope that my article, and a forth-I do hope that my article, and a forthcoming meeting to be held at the College coming meeting to be held at the College (contact me at drbensessa (contact me at drbensessa@ @hotmail.com hotmail.com for further details), can help raise awarefor further details), can help raise awareness of this subject. I also agree with Dr ness of this subject. I also agree with Dr Sandison in his plea for continued support Sandison in his plea for continued support from the College to bring this subject to from the College to bring this subject to the attention of doctors in the UK. the attention of doctors in the UK. (2005) attribute the proposed demise of the Kraepelinian proposed demise of the Kraepelinian dichotomy to advances in genetic epidemiodichotomy to advances in genetic epidemiology, and rightly emphasise the need to logy, and rightly emphasise the need to integrate data across multiple domains in integrate data across multiple domains in large numbers of people. However, it may large numbers of people. However, it may also be important to use a population-based also be important to use a population-based approach. This involves extra effort but approach. This involves extra effort but avoids being misled by convenience samples avoids being misled by convenience samples which may not be representative of the which may not be representative of the population. This is illustrated by Fig. 1 in population. This is illustrated by Fig. 1 in the editorial of Craddock & Owen which the editorial of Craddock & Owen which suggests that prototypical schizophrenia suggests that prototypical schizophrenia and prototypical bipolar disorder are relaand prototypical bipolar disorder are relatively rare in clinical populations. Work in tively rare in clinical populations. Work in population-based samples suggests that population-based samples suggests that there is an early, insidious-onset psychosis there is an early, insidious-onset psychosis with a poor outcome affecting predomiwith a poor outcome affecting predominantly men -a 'neurodevelopmental' form nantly men -a 'neurodevelopmental' form of schizophrenia which is very close to of schizophrenia which is very close to dementia praecox (Castle dementia praecox (Castle et al et al, 1998) . This , 1998). This prototypical form of schizophrenia together prototypical form of schizophrenia together with protoypical bipolar disorder accounts with protoypical bipolar disorder accounts for 50% of people with psychosis in a for 50% of people with psychosis in a treated prevalence sample, demonstrating treated prevalence sample, demonstrating the utility of Kraepelin's division. In our the utility of Kraepelin's division. In our experience affective and non-affective experience affective and non-affective psychoses can be accounted for by these psychoses can be accounted for by these prototypical forms and a further two latent prototypical forms and a further two latent classes which appear to be valid (Murray classes which appear to be valid (Murray et al et al, 2005) . Whether such empirically , 2005). Whether such empirically derived classes might provide better phenoderived classes might provide better phenotypes for genetic studies is as yet types for genetic studies is as yet undetermined. undetermined.
Until biological markers are identified Until biological markers are identified there is perhaps only one way to improve there is perhaps only one way to improve our classification. Large-scale, empirical, our classification. Large-scale, empirical, population-based studies of psychiatric population-based studies of psychiatric symptoms, demography, course, treatment symptoms, demography, course, treatment response and outcomes are suggested to response and outcomes are suggested to reclassify these disorders from first princireclassify these disorders from first principles and provide an atheoretical framework ples and provide an atheoretical framework which may capture underlying pathowhich may capture underlying pathophysiological substrates. Such studies physiological substrates. Such studies should, as described by Craddock & Owen, should, as described by Craddock & Owen, integrate both dimensional and categorical integrate both dimensional and categorical approaches but also require a developapproaches but also require a developmental perspective across the life span. mental perspective across the life span. The debate about the Kraepelinian dichotThe debate about the Kraepelinian dichotomy illustrates the lack of evidence-based omy illustrates the lack of evidence-based diagnostic classification in psychiatry as a diagnostic classification in psychiatry as a discipline. It would be fitting if psychiatric discipline. It would be fitting if psychiatric genetics, which has been severely impeded genetics, which has been severely impeded by the lack of a robust nosology, focused by the lack of a robust nosology, focused the collective will of practitioners to the collective will of practitioners to establish the evidence base required for a establish the evidence base required for a psychiatric classification which at last psychiatric classification which at last reflects nature. reflects nature. , 2005) . Other findings of a similar nature are currently emerging from our nature are currently emerging from our own studies and those of other groups, own studies and those of other groups, and we anticipate that we are entering a and we anticipate that we are entering a period during which psychiatric research period during which psychiatric research and practice will be placed on much firmer and practice will be placed on much firmer nosological foundations than has been nosological foundations than has been possible in the past. possible in the past. (2005) report an interesting randomised controlled trial evaluating randomised controlled trial evaluating cognitive-behavioural therapy (CBT) for cognitive-behavioural therapy (CBT) for refractory psychotic symptoms of schizorefractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic phrenia resistant to atypical antipsychotic medication. They conclude that patients medication. They conclude that patients should not be excluded from psychological should not be excluded from psychological help on the grounds that they are too ill to help on the grounds that they are too ill to benefit from therapy, and CBT for benefit from therapy, and CBT for psychotic symptoms should be available in psychotic symptoms should be available in in-patient facilities. in-patient facilities.
Declaration of interest
We feel the conclusions drawn by the We feel the conclusions drawn by the authors do not truly reflect their results. authors do not truly reflect their results. Valmaggia Valmaggia et al et al report that their primary report that their primary hypothesis was that CBT would be more hypothesis was that CBT would be more effective than supportive counselling in effective than supportive counselling in reducing auditory hallucinations and delureducing auditory hallucinations and delusional beliefs. They used the Positive and sional beliefs. They used the Positive and Negative Syndrome Scale (PANSS) and PsyNegative Syndrome Scale (PANSS) and Psychotic Symptoms Rating Scale (PSYRATS) chotic Symptoms Rating Scale (PSYRATS) to measure outcomes. The post-treatment to measure outcomes. The post-treatment score on the PANSS positive sub-scale of score on the PANSS positive sub-scale of those receiving CBT was not significantly those receiving CBT was not significantly different from that of the control group. different from that of the control group. On the PSYRATS no significant effect was On the PSYRATS no significant effect was found on the delusions. Benefits of CBT found on the delusions. Benefits of CBT were found on the auditory hallucinations were found on the auditory hallucinations scale for physical characteristics and cogniscale for physical characteristics and cognitive interpretation but not for emotional tive interpretation but not for emotional characteristics. However, the benefits nocharacteristics. However, the benefits noticed were not sustained at follow-up. It ticed were not sustained at follow-up. Also, if we look at the numbers needed Also, if we look at the numbers needed to treat (NNT) calculations, the authors to treat (NNT) calculations, the authors have accurately reported the lack of statistihave accurately reported the lack of statistical significance (PANSS positive symptom cal significance (PANSS positive symptom scale, NNT scale, NNT¼8, 95% CI 3-8, 95% CI 3-1; PSYRATS ; PSYRATS factor 2, NNT factor 2, NNT¼6, 95% CI 2-6, 95% CI 2-1; delusion ; delusion scale factor 1, NNT scale factor 1, NNT¼4, 95% CI 2-4, 95% CI 2-1; ; factor 2, NNT factor 2, NNT¼12, 95% CI 3-12, 95% CI 3-1). The ). The only finding with reasonable confidence only finding with reasonable confidence intervals seems to be cognitive interpretaintervals seems to be cognitive interpretation on the auditory hallucination scale of tion on the auditory hallucination scale of the PSYRATS (NNT the PSYRATS (NNT¼3, 95% CI 2-13).
3, 95% CI 2-13). The authors also draw our attention to The authors also draw our attention to the fact that clozapine is effective in 32% the fact that clozapine is effective in 32% of cases in producing a clinical improveof cases in producing a clinical improvement (NNT ment (NNT¼5, 95% CI 4-7; Wahlbeck 5, 95% CI 4-7; Wahlbeck et et al al, 1999). They seem to suggest that the , 1999). They seem to suggest that the figures from the current study reveal the figures from the current study reveal the effects of CBT to be similar to clozapine. effects of CBT to be similar to clozapine. However, it should be noted that this figure However, it should be noted that this figure reported by Wahlbeck reported by Wahlbeck et al et al is for global is for global improvement, whereas Valmaggia improvement, whereas Valmaggia et al et al do do not give any figures for global improvement not give any figures for global improvement and hence in our opinion these results are and hence in our opinion these results are not comparable. To conclude from these not comparable. To conclude from these results that CBT could induce a change results that CBT could induce a change in psychotic symptoms seems to be in psychotic symptoms seems to be overestimating the beneficial effects. overestimating the beneficial effects.
Patients with schizophrenia who are Patients with schizophrenia who are resistant to clozapine form one of the most resistant to clozapine form one of the most difficult-to-treat groups. Jones difficult-to-treat groups. Jones et al et al (2004) (2004) concluded that trial-based data supporting concluded that trial-based data supporting the wide use of CBT for people with schizothe wide use of CBT for people with schizophrenia or other psychotic illnesses are far phrenia or other psychotic illnesses are far from conclusive. The randomised confrom conclusive. The randomised controlled study of Valmaggia trolled study of Valmaggia et al et al evaluating evaluating interventions in this population is welcome. interventions in this population is welcome.
Jones, C., Cormac, I., Silveira da Mota Neto, J. I., Jones, C., Cormac, I., Silveira da Mota Neto, J. I., The authors conclude that olanzapine The authors conclude that olanzapine in combination with either lithium or in combination with either lithium or valproate was effective in improving the valproate was effective in improving the severity of depressive symptoms coexisting severity of depressive symptoms coexisting with acute mania. This conclusion is based with acute mania. This conclusion is based on statistically significant differences in on statistically significant differences in mean changes in Hamilton Rating Scale mean changes in Hamilton Rating Scale for Depression (HRSD) score. However, for Depression (HRSD) score. However, the authors have not reported the standard the authors have not reported the standard deviations for these mean changes. Hence it deviations for these mean changes. Hence it is difficult to ascertain whether the data are is difficult to ascertain whether the data are skewed. It is possible that a few patients skewed. It is possible that a few patients showing large changes on the HRSD could showing large changes on the HRSD could have skewed the data. It was also puzzling have skewed the data. It was also puzzling that the authors reported that the difference that the authors reported that the difference in the HRSD score between combination in the HRSD score between combination and monotherapy groups was larger for and monotherapy groups was larger for dysphoric patients. One would expect dysphoric patients. One would expect participants in the non-dysphoric group to participants in the non-dysphoric group to have much lower baseline scores so that have much lower baseline scores so that there would be less chance of a significant there would be less chance of a significant reduction. ( 
62).) 4.62).)
We are also of the view that reporting We are also of the view that reporting study outcomes in terms of mean changes study outcomes in terms of mean changes on a rating scale does not provide meaningon a rating scale does not provide meaningful information for clinicians. Reporting ful information for clinicians. Reporting results using dichotomous outcome results using dichotomous outcome measures such as 'improved' and 'not measures such as 'improved' and 'not improved' with a meaningful cut-off point improved' with a meaningful cut-off point defined defined a priori a priori would be helpful. would be helpful. Clinicians would be more interested in Clinicians would be more interested in outcome measures such as complete remisoutcome measures such as complete remission of symptoms, return to premorbid sion of symptoms, return to premorbid levels of functioning, etc. To address the levels of functioning, etc. To address the question of whether olanzapine is helpful question of whether olanzapine is helpful for patients with dysphoric mania it would for patients with dysphoric mania it would be helpful to know how many in the olanbe helpful to know how many in the olanzapine co-therapy group achieved complete zapine co-therapy group achieved complete remission and whether there was any statisremission and whether there was any statistical difference between groups. It would tical difference between groups. It would have been interesting if Baker have been interesting if Baker et al et al had also had also provided dichotomous outcomes based on provided dichotomous outcomes based on the Clinical Global Impression scale for the Clinical Global Impression scale for bipolar disorder (CGI-BP; Spearing bipolar disorder (CGI-BP; Spearing et al et al, , 1997), as this was administered during the 1997), as this was administered during the course of the trial and data should be course of the trial and data should be readily available. readily available.
It is not uncommon to come across It is not uncommon to come across reporting of various outcome measures reporting of various outcome measures and multiple analysis of a randomised and multiple analysis of a randomised controlled trial. However, whether this controlled trial. However, whether this adds to clinical knowledge is questionable. adds to clinical knowledge is questionable. We agree with Baker We agree with Baker et al et al that it is importthat it is important to explore the pharmacological options ant to explore the pharmacological options for dysphoric mania as the available for dysphoric mania as the available options are limited. However, we need options are limited. However, we need more pragmatic outcome measures that more pragmatic outcome measures that are easily understood by clinicians and are easily understood by clinicians and can be applied in routine practice rather can be applied in routine practice rather than being lost in multiple analysis. than being lost in multiple analysis. Systematic reviews such as that on the use Systematic reviews such as that on the use of olanzapine for mania also highlight the of olanzapine for mania also highlight the lack of pragmatic outcome measures in lack of pragmatic outcome measures in the reporting of randomised controlled the reporting of randomised controlled studies (Rendell studies (Rendell et al et al, 2003) . We hope , 2003). We hope future reports of such studies will use outfuture reports of such studies will use outcome measures that are more applicable come measures that are more applicable to the real world. to the real world. 
ECT in depression ECT in depression
Schulze-Rauschenbach Schulze-Rauschenbach et al et al (2005) found (2005) found in their comparison of unilateral electroin their comparison of unilateral electroconvulsive therapy (ECT) and repetitive convulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) transcranial magnetic stimulation (rTMS) that these two procedures have similar that these two procedures have similar efficacy in the treatment of major efficacy in the treatment of major depression. However, the rate of treatment depression. However, the rate of treatment response for ECT in their study was 46%, response for ECT in their study was 46%, well below the figures found in other well below the figures found in other studies (Medical Research Council, 1965) . studies (Medical Research Council, 1965) . The authors state that the response rate The authors state that the response rate for ECT might have been higher if a higher for ECT might have been higher if a higher dosage had been used, but that this would dosage had been used, but that this would have increased the risk of side-effects. This have increased the risk of side-effects. This argument is misleading, just as comparing argument is misleading, just as comparing a sub-therapeutic dose of amitriptyline a sub-therapeutic dose of amitriptyline and placebo would be. The authors should and placebo would be. The authors should have compared the incidence of side-effects have compared the incidence of side-effects between treatments, but at therapeutic doses. between treatments, but at therapeutic doses. This comparison would probably have conThis comparison would probably have confirmed the prevalent belief that ECT is more firmed the prevalent belief that ECT is more effective than rTMS in the treatment of effective than rTMS in the treatment of major depression (Aarre major depression (Aarre et al et al, 2003) . , 2003). (2005) compared repetitive transcranial magnetic pared repetitive transcranial magnetic stimulation (rTMS) and unilateral electrostimulation (rTMS) and unilateral electroconvulsive therapy (ECT) and reported a convulsive therapy (ECT) and reported a similar treatment response rate. The rTMS similar treatment response rate. The rTMS methodology produced an impressive methodology produced an impressive improvement with no cognitive side-effects. improvement with no cognitive side-effects.
However, the reported similar treatHowever, the reported similar treatment effect with ECT could be misleading, ment effect with ECT could be misleading, as it is partly due to the rather low success as it is partly due to the rather low success rate of ECT in this study. The Hamilton rate of ECT in this study. The Hamilton Rating Scale for Depression (HRSD) score Rating Scale for Depression (HRSD) score in the ECT group was reduced by a modest in the ECT group was reduced by a modest 35%. For comparison, the non-psychotic 35%. For comparison, the non-psychotic patients in the largest recent ECT study patients in the largest recent ECT study (the CORE study; Petrides (the CORE study; Petrides et al et al, 2001) , 2001) achieved a 74.5% reduction on the achieved a 74.5% reduction on the HRSD-24 (24-item version). .
We started an audit of ECT at our We started an audit of ECT at our regional psychiatric hospital 1 year ago. regional psychiatric hospital 1 year ago.
So far 23 consecutive patients with So far 23 consecutive patients with treatment-resistant depression, who had treatment-resistant depression, who had an HRSD-17 (17-item version) score of an HRSD-17 (17-item version) score of 15 or above (the cut-off used by Schulze-15 or above (the cut-off used by SchulzeRauschenbach Rauschenbach et al et al), have completed at ), have completed at least six ECT sessions. We observed a least six ECT sessions. We observed a 55% improvement on the HRSD-17: from 55% improvement on the HRSD-17: from 24.6 to 11.0 points. The decrease on the 24.6 to 11.0 points. The decrease on the self-rated Beck Depression Inventory was self-rated Beck Depression Inventory was 20.1 points (an improvement of 49.9%). 20.1 points (an improvement of 49.9%). This compares with a decrease of only 7.6 This compares with a decrease of only 7.6 points (24%) in the ECT group of points (24%) in the ECT group of Schulze-Rauschenbach Schulze-Rauschenbach et al et al. Even more . Even more importantly, the remission rate in their importantly, the remission rate in their study was very low. Using the remission study was very low. Using the remission criterion of criterion of 4 47 points on the HRSD-17 7 points on the HRSD-17 (Thase, 2003) , only one of their 13 ECT (Thase, 2003) , only one of their 13 ECT patients (8%) achieved remission (as shown patients (8%) achieved remission (as shown in Fig. 1 ). This contrasts with a rate of in Fig. 1 ). This contrasts with a rate of 43.5% (10 out of 23 patients) in our study 43.5% (10 out of 23 patients) in our study and 74.7% (189 out of 253 patients) in the and 74.7% (189 out of 253 patients) in the CORE study. Four of our patients scored 0 CORE study. Four of our patients scored 0 or 1 point at the end of treatment. or 1 point at the end of treatment.
There could be at least two reasons for There could be at least two reasons for the low response rate in the ECT group of the low response rate in the ECT group of Schulze-Rauschenbach Schulze-Rauschenbach et al et al. First, uni-. First, unilateral ECT is less effective than bilateral lateral ECT is less effective than bilateral ECT, and when used at a simulation inten-ECT, and when used at a simulation intensity of 100-150% above seizure threshold, sity of 100-150% above seizure threshold, it has produced only a 30% response rate it has produced only a 30% response rate (Sackeim (Sackeim et al et al, 2000) . Only four patients , 2000). Only four patients in our series and none in the CORE study in our series and none in the CORE study had unilateral ECT. Second, patients with had unilateral ECT. Second, patients with psychotic depression respond better to psychotic depression respond better to ECT (Petrides ECT (Petrides et al et al, 2001) . None of the pa-, 2001). None of the patients of Schulze-Rauschenbach tients of Schulze-Rauschenbach et al et al had had psychotic symptoms, but 13 (56.5%) in psychotic symptoms, but 13 (56.5%) in our group and 77 (30.4%) in the CORE our group and 77 (30.4%) in the CORE study did. This cannot explain all the study did. This cannot explain all the difference, as the non-psychotic patients difference, as the non-psychotic patients in our group still showed an improvement in our group still showed an improvement of 48% on both HRSD-17 and Beck of 48% on both HRSD-17 and Beck Depression Inventory scores. Depression Inventory scores.
Properly administered bilateral ECT Properly administered bilateral ECT still remains by far the most effective still remains by far the most effective treatment for severe depression. treatment for severe depression. Archives of General Psychiatry, , 57 57, 425^434. , 425^434.
Schulze-Rauschenbach, S. C., Harms, U., Schulze-Rauschenbach, S. C., Harms, U., Schlaepfer, T. E., Schlaepfer, T. E., et al et al ( (ECT) , which electroconvulsive therapy (ECT), which may be greater when bilateral ECT is used may be greater when bilateral ECT is used instead of unilateral ECT. We have little instead of unilateral ECT. We have little doubt that this is true, but bilateral ECT doubt that this is true, but bilateral ECT is associated with more unwanted effects is associated with more unwanted effects on cognition than unilateral ECT (National on cognition than unilateral ECT (National Institute for Clinical Excellence, 2003) . Institute for Clinical Excellence, 2003) . This is the main reason why unilateral This is the main reason why unilateral ECT is still frequently applied, certainly at ECT is still frequently applied, certainly at the beginning of a course of treatment. the beginning of a course of treatment. Some patients experience severe and persisSome patients experience severe and persistent memory deficits after ECT (see Donatent memory deficits after ECT (see Donahue, 2000) . In their systematic review, hue, 2000). In their systematic review, Rose Rose et al et al (2003) found that about one- (2003) found that about onethird of patients reported significant memthird of patients reported significant memory loss after ECT. One can question the ory loss after ECT. One can question the validity of this worrisome figure on methvalidity of this worrisome figure on methodological grounds, as the studies reviewed odological grounds, as the studies reviewed by Rose by Rose et al et al used questionnaires instead of used questionnaires instead of neuropsychological assessments. Nevertheneuropsychological assessments. Nevertheless, cognitive alterations can be very disless, cognitive alterations can be very disturbing for the patient, and there remains turbing for the patient, and there remains a need to examine this controversial issue a need to examine this controversial issue further. further.
In assessing the somewhat lower cliniIn assessing the somewhat lower clinical response obtained in our study comcal response obtained in our study compared with others, it should be borne in pared with others, it should be borne in mind that all our patients were treatment mind that all our patients were treatment refractory (i.e. they had unsuccessful treatrefractory (i.e. they had unsuccessful treatment response to at least two different ment response to at least two different types of antidepressants, each given in a types of antidepressants, each given in a sufficient dosage range for at least 4 weeks). sufficient dosage range for at least 4 weeks). Patients with resistance to antidepressant Patients with resistance to antidepressant treatment are known to have reduced rates treatment are known to have reduced rates of response (Sackheim of response (Sackheim et al et al, 2000) . For , 2000) . For example, less than 30% of those with example, less than 30% of those with depression who had failed to respond to depression who had failed to respond to one adequate medication trial finally one adequate medication trial finally responded to low-dose or moderate-dose responded to low-dose or moderate-dose right unilateral ECT, in contrast to about right unilateral ECT, in contrast to about 50% who had not received such an 50% who had not received such an adequate antidepressant trial (Sackheim adequate antidepressant trial (Sackheim et et al al, 2000) . Thus, the therapeutic effect of , 2000). Thus, the therapeutic effect of ECT in our study was well within the ECT in our study was well within the expected range both for the group of expected range both for the group of patients studied and the type of ECT patients studied and the type of ECT applied. It should also be noted that particiapplied. It should also be noted that participants in the CORE study (Petrides pants in the CORE study (Petrides et al et al, , 2001 ) cited by Dr Kirov and colleagues 2001) cited by Dr Kirov and colleagues were about 10 years older on average than were about 10 years older on average than patients in our study, and that ECT patients in our study, and that ECT response rates in the CORE study were response rates in the CORE study were higher for older patients. higher for older patients.
We have stated quite explicitly that our We have stated quite explicitly that our study was not designed to compare the study was not designed to compare the absolute or relative effectiveness of repetiabsolute or relative effectiveness of repetitive transcranial magnetic stimulation tive transcranial magnetic stimulation (rTMS) or ECT. As outlined in our paper, (rTMS) or ECT. As outlined in our paper, some preliminary randomised trials suggest some preliminary randomised trials suggest that rTMS might be as effective even as that rTMS might be as effective even as bilateral ECT in nonbilateral ECT in non-psychotic patients psychotic patients but, although the metabut, although the meta-analytic evidence analytic evidence for the clinical efficacy of ECT is strong, for the clinical efficacy of ECT is strong, the evidence for strong efficacy of rTMS the evidence for strong efficacy of rTMS in depression is less conclusive. in depression is less conclusive.
Our primary intention was to highlight Our primary intention was to highlight the continuing need to delineate the cognithe continuing need to delineate the cognitive side-effects of ECT in comparison with tive side-effects of ECT in comparison with other treatments. Weighing benefits and other treatments. Weighing benefits and side-effects of a specific form of ECT treatside-effects of a specific form of ECT treatment for a specific patient may have to take ment for a specific patient may have to take into account age, prior response to treatinto account age, prior response to treatments, sensitivity to memory side-effects ments, sensitivity to memory side-effects and other factors. Physicians and patients and other factors. Physicians and patients need better evidence about such sideneed better evidence about such sideeffects, preferably from randomised effects, preferably from randomised controlled trials, but also from audits such controlled trials, but also from audits such as that reported by Kirov as that reported by Kirov et al et al, to make , to make informed decisions on the use of ECT, informed decisions on the use of ECT, particularly as other forms of treatment particularly as other forms of treatment become available. become available. : 42% of admissions in Manchester were for schizophrenia and related were for schizophrenia and related psychoses (national average 26%), with psychoses (national average 26%), with only 18% for depression or anxiety only 18% for depression or anxiety (national average 29.6%) and 6.5% for (national average 29.6%) and 6.5% for substance misuse (national average 19.1%). substance misuse (national average 19.1%). Further examination of the admissions for Further examination of the admissions for substance misuse in Manchester showed substance misuse in Manchester showed that 57% were for psychoses secondary to that 57% were for psychoses secondary to alcohol or drug misuse. alcohol or drug misuse.
Our own earlier analyses of admissions Our own earlier analyses of admissions in the north west of England (Harrison in the north west of England (Harrison et et al al, 1995) also found marked variation , 1995) also found marked variation according to diagnostic group and according to diagnostic group and suggested that health districts with higher suggested that health districts with higher levels of deprivation admitted a higher prolevels of deprivation admitted a higher proportion of patients with psychotic diagportion of patients with psychotic diagnoses and fewer patients with anxiety and noses and fewer patients with anxiety and depression. Similarly, the King's Fund depression. Similarly, the King's Fund report into London's mental health (King's report into London's mental health (King's Fund, 1997) argued that a high proportion Fund, 1997) argued that a high proportion of admissions for schizophrenia reflected of admissions for schizophrenia reflected increased need for services. This could increased need for services. This could explain some of the regional variation in explain some of the regional variation in admissions according to diagnostic group admissions according to diagnostic group reported by Thompson reported by Thompson et al et al and our own and our own recent findings. Admissions for substance recent findings. Admissions for substance misuse may also be influenced by deprivamisuse may also be influenced by deprivation and availability of in-patient beds, tion and availability of in-patient beds, with some areas only admitting patients with some areas only admitting patients with secondary psychoses rather than drug with secondary psychoses rather than drug or alcohol dependence. or alcohol dependence.
The continued variation in the use of inThe continued variation in the use of inpatient facilities across England requires patient facilities across England requires further attention, particularly as it suggests further attention, particularly as it suggests that current means of resource allocation that current means of resource allocation do not adequately address the marked do not adequately address the marked impact of deprivation on need for mental impact of deprivation on need for mental health services. health services. 
Obesity and schizophrenia Obesity and schizophrenia
After reading less than half of 'Metabolic After reading less than half of 'Metabolic syndrome and schizophrenia' (Thakore, syndrome and schizophrenia' I checked the Declaration of interest 2005) I checked the Declaration of interest and found the expected link to the pharmaand found the expected link to the pharmaceutical industry. On rereading the whole ceutical industry. On rereading the whole paper carefully I could not pinpoint a single paper carefully I could not pinpoint a single statement that seemed wrong. However, statement that seemed wrong. However, the uneasy general impression remained the uneasy general impression remained that the author attempted to suggest that that the author attempted to suggest that the metabolic syndrome was rather a result the metabolic syndrome was rather a result of schizophrenia itself and/or the associated of schizophrenia itself and/or the associated stress than the antipsychotic drugs. Therestress than the antipsychotic drugs. Therefore, I would like to draw attention to the fore, I would like to draw attention to the high probability that patients with schizohigh probability that patients with schizophrenia were rarely overweight before the phrenia were rarely overweight before the advent of neuroleptics. First, Kretschmer advent of neuroleptics. First, found that 50.3% of 5233 people (1961) found that 50.3% of 5233 people with schizophrenia had a leptosome (or with schizophrenia had a leptosome (or asthenisch asthenisch) body build, for which he mea-) body build, for which he measured an average waist/hip ratio of 0.67 sured an average waist/hip ratio of 0.67 (74.1/84.7 cm) in men and 0.82 (67.7/ (74.1/84.7 cm) in men and 0.82 (67.7/ 82.2 cm) in women. Only 13.7% of 5233 82.2 cm) in women. Only 13.7% of 5233 people with schizophrenia were people with schizophrenia were pyknisch pyknisch, , characterised by a strong development of characterised by a strong development of circumference of the holes for the intestines circumference of the holes for the intestines ( (starke Umfangsentwicklung der Eingeweistarke Umfangsentwicklung der Eingeweidehohlen dehöhlen) and an average waist/hip ratio of ) and an average waist/hip ratio of 0.97 (88.8/92.0 cm) in men and 0. 84 (78.7/ 0.97 (88.8/92 .0 cm) in men and 0.84 (78.7/ 94.2 cm) in women. The rest of the 94.2 cm) in women. The rest of the schizophrenia sample was classified as schizophrenia sample was classified as athletic, dysphasic or athletic, dysphasic or uncharakteristisch uncharakteristisch (not typical of any of the aforementioned).
(not typical of any of the aforementioned). Among the 1361 people with manicAmong the 1361 people with manicdepressive illness, 64.6% were depressive illness, 64.6% were pyknisch pyknisch and only 19.2% leptosome. The leptosome and only 19.2% leptosome. The leptosome body build, which does not seem to indicate body build, which does not seem to indicate a risk of developing the metabolic syna risk of developing the metabolic syndrome, was thought of as typical for drome, was thought of as typical for schizophrenia. schizophrenia.
Second, I asked a student to classify the Second, I asked a student to classify the patients with schizophrenia on old photopatients with schizophrenia on old photographs in Bleuler's textbook (1969) as graphs in Bleuler's textbook (1969) as probably underweight, normal weight or probably underweight, normal weight or overweight, without letting her know the overweight, without letting her know the reason. She quite rightly protested that she reason. She quite rightly protested that she could not carry out the task with any could not carry out the task with any certainty. However, as she appears rather certainty. However, as she appears rather underweight herself and as most people underweight herself and as most people tend to use themselves as a yardstick, it is tend to use themselves as a yardstick, it is unlikely that she underestimated the numunlikely that she underestimated the number of overweight patients with schizober of overweight patients with schizophrenia. She classified 25% (5 out of 20) phrenia. She classified 25% (5 out of 20) as overweight, 60% (12 out of 20) as as overweight, 60% (12 out of 20) as normal weight and 15% (3 out of 20) as normal weight and 15% (3 out of 20) as underweight. Thus, in spite of Thakore's underweight. Thus, in spite of Thakore's paper, I still think that neuroleptic drugs paper, I still think that neuroleptic drugs contribute considerably to the development contribute considerably to the development of obesity and its consequences. of obesity and its consequences.
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Author's reply:
Author's reply: In response to Professor
In response to Professor Thiels letter, intra-abdominal fat (IAF) is Thiels letter, intra-abdominal fat (IAF) is critical in determining the overall risk of critical in determining the overall risk of physical morbidity and one does not need physical morbidity and one does not need to be overweight, or indeed obese in the to be overweight, or indeed obese in the conventional sense, to have an excess of conventional sense, to have an excess of IAF . For example, patients IAF . For example, patients with melancholic depression, who by defiwith melancholic depression, who by definition have usually lost weight, have twice nition have usually lost weight, have twice as much visceral fat as matched controls, as much visceral fat as matched controls, and have higher mortality rates than the and have higher mortality rates than the general population (Thakore general population (Thakore et al et al, 1997) . , 1997). Hence, the patients with schizophrenia Hence, the patients with schizophrenia described by Kretschmer may have been described by Kretschmer may have been underweight or of normal weight but still underweight or of normal weight but still have carried excessive amounts of IAF, have carried excessive amounts of IAF, which would have increased their risk of which would have increased their risk of developing a host of physical problems. developing a host of physical problems.
The waist/hip ratio is an indirect The waist/hip ratio is an indirect anthropometric measure of IAF whose anthropometric measure of IAF whose value is greatly influenced by exactly where value is greatly influenced by exactly where the tape measure is placed. Using a direct the tape measure is placed. Using a direct measure of IAF, computed tomographic measure of IAF, computed tomographic scanning, we have shown in two separate scanning, we have shown in two separate studies that first-episode drug naıve nonstudies that first-episode drug naïve nonobese patients with schizophrenia have over obese patients with schizophrenia have over three times as much IAF as matched three times as much IAF as matched controls (Thakore controls (Thakore et al et al, 2002; Ryan , 2002; Ryan et al et al, , 2004) . The amounts of IAF in both of these 2004). The amounts of IAF in both of these samples were far in excess of what one samples were far in excess of what one would see in simple obesity, but were simiwould see in simple obesity, but were similar to what one might observe in patients lar to what one might observe in patients with Cushing's syndrome. There is little with Cushing's syndrome. There is little doubt that most of the widely used doubt that most of the widely used neuroleptics (old and new) cause weight neuroleptics (old and new) cause weight gain. Yet, using computed tomographic gain. Yet, using computed tomographic scanning, an acknowledged gold standard, scanning, an acknowledged gold standard, we have shown that there is no significant we have shown that there is no significant increase in IAF with two commonly used increase in IAF with two commonly used atypical antipsychotics (Ryan atypical antipsychotics (Ryan et al et al, 2004) . , 2004). Therefore, we should be asking questions Therefore, we should be asking questions such as what has a greater physical impact such as what has a greater physical impact on patients with schizophrenia -the illness, on patients with schizophrenia -the illness, with all of its associated stress and poor with all of its associated stress and poor lifestyle choices, or the medications used lifestyle choices, or the medications used to control symptomatology? to control symptomatology?
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